CLDN1 and neoplasm: In a recent study of Roehlen et al. targeting non-junctional CLDN1 (on the basolateral membrane of the human hepatocyte) markedly suppressed tumor growth and invasion in cell line-based models of hepatocellular carcinoma and patient-derived 3D ex vivo models.